Human tRNALys3 is used by HIV virus as a primer for the reverse transcription of its genome. The 18 nucleotides of at the 3'-end of the tRNALys3 are hybridized to a complementary sequence of the viral RNA called the primer binding site. A screen against the human tRNALys3 over a peptide library designed to target RNA has been performed. Of the 175 hexapeptides tested, three were found to bind to the D-stem of tRNALys3. Alaninescanning was used to define the determinants of the interaction between the peptides and tRNALys3. They also bind to two other tested tRNAs, also at the level of the D-stem and loop, although the nucleotide sequence of the stem differs in one of them. These short peptides thus recognize specific structural features within the D stem and loop of tRNAs.
Introduction
The essential role of RNA in many biological processes makes RNA an attractive target in drug discovery. There are many potential RNA targets, including RNA that is involved in cellular proteins interaction such as transcription, splicing, and translation and, RNA that is involved in viral infection such as human immunodeficiency virus (HIV). Several systematic screens have been performed against fragments of the HIV-1 genomic RNA, but in all cases, the high affinity hits were strongly cationic [1] [2] [3] and their recognition was dominated by electrostatic effects that are often poorly selective. There is thus a need for strategies based on high selectivity rather than on high affinity. In this context, interaction screening by NMR can be an attractive technique, as it can both detect weak interactions and provide structural information on ligand-binding modes (for reviews on NMR-based screening, see [4] [5] [6] [7] [8] [9] ).
Using flow-injection NMR, we have screened against the human tRNALys3 over a peptide library designed to target RNA [10] . tRNALys3 is used by HIV-1 as a primer to the reverse transcription of its genome. The 18 nucleotides at the 3' end of tRNALys3 are hybridized to a complementary fragment of the viral RNA called the primer binding site (PBS). The aim of this study was to find molecules that bind specifically to tRNALys3 and that could provide leads for inhibitors of the formation of the HIV-1 reverse transcription initiation complex. In a first approach, a chemical library of short peptides was used, since these can be easily obtained and provide a rich variety of pharmacophore models for further development.
Peptidomimetic modification of active peptides could then provide biostable analogs [11] . hal-00219760, version 1 -27 Jan 2008
Materiels and Methods

Sample preparation
Human tRNALys3 was expressed in vivo from a recombinant plasmid and purified as previously described [12] . tRNAfMet and tRNAmMet were expressed and purified similarly [13, Wallis, 1995 #370 ]. The peptide library has been described [10] , for NMR analyses, the peptide stocks (100 mM in DMSO-d6) into 5mM imidazole-HCl, pH7, prepared in 90%
NMR experiments
Experiments were recorded on a Bruker Avance DRX 600 spectrometer equipped with a 3mm triple-resonance flow-injection probe. The probe was connected to a Gilson 215 liquid handler controlled by the NMR console (Bruker BEST system). For tRNA:peptide mixtures, solvent suppression was achieved by using the 'jump-and-return' sequence to avoid the saturation of imino protons [14] . Samples for 1D NMR screening contained 0.3 mM of tRNA and 1.2 mM of peptide in 5mM imidazole buffer pH 7, in a total volume of 200 µl in 96-well
plates. The injected sample volumes were 160 µl. As imino chemical shifts in RNA are sensitive to pH, we used the spacing between the two aromatic NMR signals as an internal pH probe, which enabled us to eliminate false positives resulting from the pH shifts induced by ligand addition. For ligands identified in the primary screen, 1 H-15 N JR-HMQC spectra [15] were recorded using a sample containing 0. hal-00219760, version 1 -27 Jan 2008
Results and Discussion
The human tRNALys3 is used by HIV-1 as a primer for the reverse transcription of its genome. Indeed, the 18 nucleotides at the 3' end of tRNALys3 are complementary to the primer binding site in the viral RNA (for reviews, see [17] [18] [19] ). This tRNALys3-viral RNA duplex is then recognised by the reverse transcriptase (for reviews [17, 20] ) which can start the elongation of the minus DNA strand. In order to prevent the formation of the initiation complex (tRNALys3/viral RNA), an attractive strategy would be to isolate ligands that bind to tRNALys3 and that could then hinder its recruitment by viral factors : the nucleocapsid protein, the reverse transcriptase or the viral RNA. For this purpose, we previously designed a library of hexapeptides to screen RNA ligands [10] . Briefly, we used a heuristic algorithmic approach to select in silico a set of 175 peptides, which simultaneously satisfies a set of physico-chemical constraints (charge, solubility, amino acid composition) and performs an optimised sampling of the peptide sequence space. In particular, strongly basic sequences (pI > 9) were systematically eliminated in order to avoid non-specific electrostatic binding to RNA.
In order to reduce the amounts of target tRNA used in the screening process, we first increases. These magnitude of Kd are of the same order of one found for a peptide that bind to TAR RNA [22] . No NOE can be directly observed between the protons of the peptide and the imino groups of tRNALys3, probably due to the low affinity of P1 for tRNALys3. In the same way, no trNOE has been observed. In order to characterize the residues crucial to the binding to tRNALys3, each residue of the peptide P1 was sequentially mutated by an alanine. Then, the impact of the mutation for the binding to tRNALys3 was analysed by the observation of the 1D NMR spectra of the tRNALys3 imino region in presence of each modified peptide. peptides to two others tRNA, E. coli tRNAfMet that has the same sequence as human tRNALys3 in the D-arm and E. coli tRNAmMet that has a different sequence (see [23] for the sequences). All three peptides were found to bind to tRNAfMet and tRNAmMet (data not shown) and the binding also occurs in the D-arm of these tRNAs. Therefore, these peptides appear to be specific for the structure of the D stem and loop of tRNA, independently of the nucleotide sequence within the D-stem.
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Conclusion
The present study demonstrates that flow injection NMR screening of a small optimized library of short peptides is a viable approach for isolating weak but specific ligands of a structured RNA. The three identified peptides are structure-specific, and could provide leads for the design of high affinity ligands. Such short peptides could be further optimised and/or coupled with other RNA-binding pharmacophores, such as polyamines, aminoglycoside fragments or intercalating groups and provide useful tools for studying the structure or interfering with the metabolism of such structured RNA. 
